In the Zone
In this series, we focus on some of the ‘hot topics’ in bioanalysis. Explore the topics we have covered so far with our insightful videos, infographics, editorials and expert podcasts, as well as journal articles from Bioanalysis made available to Bioanalysis Zone members. Topics coming soon include: COVID-19 vaccine assay development, flow cytometry, HRMS and virtual audits and software.
The last 10–15 years have seen an increased interest in cell and gene therapies (CGTs). CGTs refer to a group of drug products or therapeutics in which the active pharmaceutical agent ...Read more
High-throughput screening of candidate compounds during drug discovery has been hindered by the limitations of traditional liquid chromatography. Acoustic Ejection Mass Spectrometry ...Read more
Ligand-binding assays (LBAs) including plate-based enzyme-linked immunosorbent assays (ELISAs) are a mainstay of the bioanalytical quantitation of biotherapeutic drugs in ...Read more
Assay development enables a drug or biochemical to be tested or measured. When analyzing a peptide of interest, it is important to choose and develop assays that are specific, sensitive ...Read more
Bioanalysis is a critical part of the discovery and development of peptide therapeutics. LC–MS is an established technique for quantifying peptides; however, analysis of target analytes ...Read more